| Literature DB >> 26827741 |
Jorge Rodrigues de Sousa1, Raphael Primo Martins de Sousa1, Tinara Leila de Souza Aarão2, Leonidas Braga Dias3, Francisca Regina Oliveira Carneiro1, Hellen Thais Fuzii3, Juarez Antonio Simões Quaresma4.
Abstract
The clinical manifestations of the leprosy depend on host immune response and the macrophages are the primary cells involved in this process. M1 and M2 cells exhibited distinct morphology, distinct surface marker profiles, as well as different cytokine and chemokine secretion. Macrophages express receptors such as CD163, CD68, CD206, and costimulatory molecules such as CD80 and CD86, and cytokines that trigger a suppressive or inflammatory response. Thirty-three untreated patients were selected, 17 patients had the tuberculoid leprosy (TT) and 16 had the lepromatous leprosy (LL). We performed immunohistochemistry to detect IL-13, IL-10, TGF-β, FGF-β, CD163, CD68, arginase 1. M2 macrophages showed significant differences between the groups studied with increase in the expression of costimulatory molecules (CD68 and CD163), arginase 1 and cytokines (IL-10, IL-13, TGF-β and FGF-b) in the LL form. Response of M2 macrophages emerge as an alternative for a better understanding of the innate immunity in the polar forms of leprosy, highlighting the role of cytokines, arginase 1 and costimulatory molecules in the repair and suppressive responses in the lepromatous form of the disease.Entities:
Keywords: Clinical aspect; Immunopathology; M2 macrophage; Macrophage
Mesh:
Substances:
Year: 2016 PMID: 26827741 DOI: 10.1016/j.actatropica.2016.01.008
Source DB: PubMed Journal: Acta Trop ISSN: 0001-706X Impact factor: 3.112